Article info
PDFOriginal research
The role of clinical trials in the sustainability of the Italian national health service cancer drug expenditure
- Correspondence to Dr Lorenzo Gasperoni, Oncological Pharmacy Unit, IRST, Meldola 47014, Emilia-Romagna, Italy; lorenzo.gasperoni{at}irst.emr.it
Citation
The role of clinical trials in the sustainability of the Italian national health service cancer drug expenditure
Publication history
- Received March 7, 2022
- Accepted April 19, 2022
- First published May 16, 2022.
Online issue publication
February 21, 2023
Article Versions
- Previous version (21 February 2023).
- Previous version (21 February 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© European Association of Hospital Pharmacists 2023. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, an indication of whether changes were made, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.